Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
More than 50% of metastatic melanoma patients have a specific mutation in the serine/threonine kinase BRAF. This results in constitutive activation of the RAS-RAF-MEK-ERK-MAP kinase pathway, which causes uncontrolled cell growth. | Ifferential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines